Home / RGRX : OTC

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does RGRX make money? Does RGRX have pricing power? What's the Earnings Whisper? Will RGRX profit more as the business scales? What is RGRX's management track record? Is RGRX's current price justified?

RegeneRx Biopharmaceuticals, Inc.

$0 +$0.00 (+266.67%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

Day Range

$0$0.16

Year Range

$0$0.16

Market Cap

1.65K

AVG Volume

Trailing/Forward PE

-0/-

PEG ratio

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (USD)

RGRX Revenue (USD) by year
Period	Revenue (USD)
2022	76.76K
2021	76.76K
2020	76.76K
2019	76.76K
2018	69.67K
2017	56.65K
2016	93.31K
2015	60.61K
2014	0
2013	0

Net Income (USD)

RGRX Net Income (USD) by year
Period	Net Income (USD)
2022	-1.73M
2021	-1.6M
2020	-1.52M
2019	-1.4M
2018	-1.99M
2017	286.49K
2016	228.98K
2015	-5.27M
2014	-2.75M
2013	-671.34K

Operating Income (USD)

RGRX Operating Income (USD) by year
Period	Operating Income (USD)
2022	-1.4M
2021	-1.33M
2020	-1.29M
2019	-1.26M
2018	-1.32M
2017	-1.44M
2016	-1.67M
2015	-1.71M
2014	-1.56M
2013	-914.25K

EBITDA (USD)

RGRX EBITDA (USD) by year
Period	EBITDA (USD)
2022	-9
2021	55.51K
2020	-1.29M
2019	-1.24M
2018	-1.9M
2017	559.02K
2016	405.73K
2015	-5.09M
2014	-2.56M
2013	-780.74K

Cash Flows (USD)

RGRX Cash Flows (USD) by year
Period	Cash Flows (USD)
2022	-940.72K
2021	-990.3K
2020	-1.01M
2019	-1.14M
2018	-888.29K
2017	-663.09K
2016	-1.07M
2015	-525.34K
2014	-1.71M
2013	-781.6K

EPS (USD)

RGRX EPS (USD) by year
Period	EPS (USD)
2022	-0.01
2021	-0.01
2020	-0.01
2019	-0.01
2018	-0.02
2017	0
2016	1.98
2015	-0.05
2014	-2.9
2013	-0.01

Expenses (USD)

RGRX Expenses (USD) by year
Period	Expenses (USD)
2022	1.48M
2021	1.41M
2020	1.38M
2019	1.34M
2018	1.39M
2017	1.5M
2016	1.77M
2015	1.77M
2014	1.56M
2013	943.74K

Cash & Debt (USD)

RGRX Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2022	290.89K
2021	1.23M
2020	427.9K
2019	639.92K
2018	237.26K
2017	181.71K
2016	769.5K
2015	317.63K
2014	844.04K
2013	6.31K

Debt ratios

RGRX Debt ratios by year
Period	Debt ratios
2022	-0.47
2021	0.02
2020	-0.15
2019	-0.04
2018	0.03
2017	-0.07
2016	-0.01
2015	-0.04

Margins

RGRX Margins by year
Period	Margins
2022	100%
2021	99.99%
2020	99.99%
2019	99.91%
2018	99.88%
2017	99.74%
2016	99.74%
2015	99.66%
2012	100%

Return on Capital

RGRX Return on Capital by year
Period	Return on Capital
2022	50.12%
2021	71.71%
2020	53.94%
2019	60.01%
2018	90.13%
2017	-6.96%
2016	-3.77%
2015	78.17%
2014	160.88%
2013	41.4%

Shares Outstanding

RGRX Shares Outstanding by year
Period	Shares Outstanding
2022	143.55M
2021	143.48M
2020	133.44M
2019	131.51M
2018	128.52M
2017	109.24M
2016	106.79M
2015	101.64M
2014	101.32M
2013	81.73M

Book Value Per Share (USD)

RGRX Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2022	-0.02
2021	-0.02
2020	-0.02
2019	-0.02
2018	-0.02
2017	-0.04
2016	-0.06
2015	-0.07
2014	-0.02
2013	-0.02

Total Assets (USD)

RGRX Total Assets (USD) by year
Period	Total Assets (USD)
2022	382.18K
2021	1.28M
2020	551.79K
2019	711.76K
2018	281.04K
2017	227.07K
2016	862.4K
2015	358.22K
2014	949.19K
2013	42.73K

Employee Count

RGRX Employee Count by year
Period	Employee Count
2022	2
2021	3
2020	3
2019	3
2018	3
2017	3
2016	3
2015	3
2014	2
2013	5

PE Ratio

RGRX PE Ratio by year
Period	PE Ratio
May 18	7626.18
May 18	7626.18
Apr 18	8388.8
Apr 18	7626.18
Apr 18	8045.62
Apr 18	8270.6
Mar 18	8388.8
Nov 17	1845.29
Nov 17	2050.32
Oct 17	2544.51
Oct 17	2333.12
Oct 17	2333.12
Oct 17	2262.42
Sep 17	2333.12
Sep 17	2403.82
Sep 17	2036.18
Sep 17	2049.61
Sep 17	1979.62
Aug 17	1873.57
Aug 17	789.99
Aug 17	798.61
Aug 17	868.7
Jul 17	804.35
Jul 17	757.82
Jul 17	740.87
Jul 17	753.79
Jun 17	775.63
Jun 17	775.63
Jun 17	746.9
Jun 17	804.35
Jun 17	804.35
May 17	817.28
May 17	804.35
May 17	12964.85
May 17	13757.67
Apr 17	13398.57
Apr 17	13519.82
Apr 17	13990.85
Apr 17	13990.85
Mar 17	13524.48

Free Cash Flow Yield

RGRX Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-521.85%
Sep 26	-521.85%
Aug 26	-820.06%
Aug 26	-820.06%
Aug 26	-820.06%
Aug 26	-820.06%
Jul 26	-956.73%
Jul 26	-956.73%
Jul 26	-956.73%
Jul 26	-956.73%
Jul 26	-956.73%
Jun 26	-956.73%
Jun 26	-956.73%
Jun 26	-956.73%
Jun 26	-956.73%
May 26	-956.73%
May 26	-1148.08%
May 26	-1148.08%
May 26	-1148.08%
May 26	-1148.08%
Apr 26	-1148.08%
Apr 26	-1148.08%
Apr 26	-1913.47%
Apr 26	-1913.47%
Mar 26	-1913.47%
Mar 26	-1913.47%
Mar 26	-1913.47%
Mar 26	-1913.47%
Feb 26	-1913.47%
Feb 26	-1913.47%
Feb 26	-1913.47%
Feb 26	-1913.47%
Jan 26	-1913.47%
Jan 26	-1913.47%
Jan 26	-1913.47%
Jan 26	-1913.47%
Jan 26	-1913.47%
Dec 25	-1913.47%
Dec 25	-1913.47%
Dec 25	-1913.47%
Dec 25	-1913.47%
Nov 25	-2870.2%
Nov 25	-2870.2%
Nov 25	-2870.2%
Nov 25	-2870.2%
Oct 25	-2870.2%
Oct 25	-2870.2%
Oct 25	-3.57%
Oct 25	-3.57%
Oct 25	-3.57%
Sep 25	-2870.2%
Sep 25	-2870.2%
Sep 25	-2870.2%
Sep 25	-2870.2%
Aug 25	-2870.2%
Aug 25	-2870.2%
Aug 25	-2870.2%
Aug 25	-2870.2%
Aug 25	-114.81%
Jul 25	-2870.2%
Jul 25	-2870.2%
Jul 25	-2870.2%
Jul 25	-2870.2%
Jun 25	-2870.2%
Jun 25	-2870.2%
Jun 25	-2870.2%
Jun 25	-2870.2%
May 25	-2870.2%
May 25	-2870.2%
May 25	-2870.2%
May 25	-2870.2%
May 25	-2870.2%
Apr 25	-2870.2%
Apr 25	-2870.2%
Apr 25	-2870.2%
Apr 25	-410.03%
Mar 25	-410.03%
Mar 25	-410.03%
Mar 25	-410.03%
Mar 25	-410.03%
Feb 25	-410.03%
Feb 25	-410.03%
Feb 25	-410.03%
Feb 25	-410.03%
Jan 25	-410.03%
Jan 25	-410.03%
Jan 25	-410.03%
Jan 25	-410.03%
Jan 25	-410.03%
Dec 24	-410.03%
Dec 24	-7.83%
Dec 24	-410.03%
Dec 24	-410.03%
Nov 24	-410.03%
Nov 24	-410.03%
Nov 24	-410.03%
Nov 24	-410.03%
Nov 24	-410.03%
Oct 24	-410.03%
Oct 24	-410.03%

Price to Sales

RGRX Price to Sales by year
Period	Price to Sales
Sep 26	2.06
Sep 26	2.06
Aug 26	1.31
Aug 26	1.31
Aug 26	1.31
Aug 26	1.31
Jul 26	1.12
Jul 26	1.12
Jul 26	1.12
Jul 26	1.12
Jul 26	1.12
Jun 26	1.12
Jun 26	1.12
Jun 26	1.12
Jun 26	1.12
May 26	1.12
May 26	0.93
May 26	0.93
May 26	0.93
May 26	0.93
Apr 26	0.93
Apr 26	0.93
Apr 26	0.56
Apr 26	0.56
Mar 26	0.56
Mar 26	0.56
Mar 26	0.56
Mar 26	0.56
Feb 26	0.56
Feb 26	0.56
Feb 26	0.56
Feb 26	0.56
Jan 26	0.56
Jan 26	0.56
Jan 26	0.56
Jan 26	0.56
Jan 26	0.56
Dec 25	0.56
Dec 25	0.56
Dec 25	0.56
Dec 25	0.56
Nov 25	0.37
Nov 25	0.37
Nov 25	0.37
Nov 25	0.37
Oct 25	0.37
Oct 25	0.37
Oct 25	300.98
Oct 25	300.98
Oct 25	300.98
Sep 25	0.37
Sep 25	0.37
Sep 25	0.37
Sep 25	0.37
Aug 25	0.37
Aug 25	0.37
Aug 25	0.37
Aug 25	0.37
Aug 25	9.35
Jul 25	0.37
Jul 25	0.37
Jul 25	0.37
Jul 25	0.37
Jun 25	0.37
Jun 25	0.37
Jun 25	0.37
Jun 25	0.37
May 25	0.37
May 25	0.37
May 25	0.37
May 25	0.37
May 25	0.37
Apr 25	0.37
Apr 25	0.37
Apr 25	0.37
Apr 25	2.62
Mar 25	2.62
Mar 25	2.62
Mar 25	2.62
Mar 25	2.62
Feb 25	2.62
Feb 25	2.62
Feb 25	2.62
Feb 25	2.62
Jan 25	2.62
Jan 25	2.62
Jan 25	2.62
Jan 25	2.62
Jan 25	2.62
Dec 24	2.62
Dec 24	137.03
Dec 24	2.62
Dec 24	2.62
Nov 24	2.62
Nov 24	2.62
Nov 24	2.62
Nov 24	2.62
Nov 24	2.62
Oct 24	2.62
Oct 24	2.62

EV/EBITDA

RGRX EV/EBITDA by year
Period	EV/EBITDA
Nov 22	40646.23
Nov 22	39642.22
Oct 22	40408.44
Oct 22	46538.2
Oct 22	46987.36
Oct 22	42284.36
Sep 22	37000.08
Sep 22	39642.22
Sep 22	45243.55
Sep 22	43341.21
Sep 22	44926.5
Aug 22	45058.6
Aug 22	42284.36
Aug 22	48361.28
Aug 22	42284.21
Jul 22	48346.46
Jul 22	44426.9
Jul 22	49574.59
Jul 22	39200.82
Jul 22	40507.34
Jun 22	42231.95
Jun 22	47039.94
Jun 22	45210.81
Jun 22	48346.46
May 22	49652.98
May 22	47144.46
May 22	49109.37
May 22	51668.29
Apr 22	28431.24
Apr 22	41355.07
Apr 22	46188.58
Apr 22	43293.65
Apr 22	47377.58
May 18	3909.08
May 18	3909.08
Apr 18	4299.9
Apr 18	3909.08
Apr 18	4124.03
Apr 18	4239.32
Mar 18	4299.9
Nov 17	1653.12
Nov 17	1836.75
Oct 17	2279.39
Oct 17	2090.05
Oct 17	2090.05
Oct 17	2026.72
Sep 17	2090.05
Sep 17	2153.37
Sep 17	1824.09
Sep 17	1836.12
Sep 17	1773.43
Aug 17	1678.45
Aug 17	754.34
Aug 17	762.57
Aug 17	829.49
Jul 17	768.05
Jul 17	723.62
Jul 17	707.44
Jul 17	719.78
Jun 17	740.63
Jun 17	740.63
Jun 17	713.2
Jun 17	768.05
Jun 17	768.05
May 17	780.4
May 17	768.05
May 17	7317.02
May 17	7764.46
Apr 17	7561.8
Apr 17	7630.23
Apr 17	7896.06
Apr 17	7896.06
Mar 17	7632.86

No video analysis for this stock yet. Request one from our team.

AI Analysis

RegeneRx Biopharmaceuticals, Inc.

Video analysis: RGRX

Similar companies